- Sources fused
- 2
- Ownership hops held
- 18
- Resolved records
- 1
An absent edge means not yet observed — never does not exist.
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED
SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED — active UK company, incorporated 2015 (oo:GB-COH-09389074). UBO chain traced 18 hops, 4 owners, 5 holdings, 16…
Ownership resolves 18 hops deep toward the ultimate beneficial owner.
Investigative lead by resolved identity, not a legal determination.
Registry identity
- Status
- active
- Incorporated
- 2015-01-14
- Legal form
- ltd
- Activity
- 74909
- Registered office
- 12b Granta Park Great Abington, Cambridge, CB21 6GQ, England
Also appears in
GLEIFThe same real-world entity, resolved across sources.
Ownership & control
Links are shown as observed in a source registry — we do not currently hold ownership end dates, so a link here may since have ended. Each row carries its source; check it before relying on currency.
- SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED
- SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED
18-step ownership / control trace to the ultimate beneficial owner — cited at every hop. Unlock the full chain.
Everything we hold on this subject, for one price — every hop to the ultimate owner, filing history, sanctions exposure, and the asset layer (property, vessels, aircraft) — as PDF and JSON, every claim linked to its source.
Everything we hold on SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED, resolved and sourced — yours to keep, no subscription.
- UBO trace
- Branded PDF + un-redacted JSON · every claim linked to its source
- Re-download for 90 days
UBO trace
Guest checkout · email only · re-download 90 days. Or subscribe from €99.
4 items you can read right now — no account, no payment.
- Identity, address & registry profile
- Sanctions & watchlist detail
- Direct connections (1 hop)
- Community notes
2 more items, hidden until you unlock this dossier. The badge on each row names the dossier that includes it.
- Full ownership trace to the UBODOSSIER
- Full export (PDF + un-redacted JSON) & change alertsDOSSIER
Register record, filings & financials
live · Companies House- Company no.
- 09389074
- Status
- active
- Type
- ltd
- Incorporated
- 2015-01-14
- Registered office
- 12b Granta Park Great Abington, Cambridge, CB21 6GQ, England
- SIC
- 74909
People & control
21 parties · 7 currentEvery officer, person with significant control and cross-company role we hold, resolved into one entry per party. Roles are registry records, not a claim of control.
- AHMED, Syed Waqas
- director · British · appointed 2023-03-29 · Companies House
- CAMERON, Euan Daney Ross
- director · British · appointed 2023-03-29 · Companies House
- GREEN, Georgina Adams
- director · British · appointed 2024-04-18 · Companies House
- OAKWOOD CORPORATE SECRETARY LIMITED
- corporate secretary · appointed 2022-11-29 · Companies House
- Ppd International Investments Limited
- corporate PSC · 75–100% shares · United Kingdom · since 2016-11-17 · CH · PSC register
Also holds roles at 4 other companies- PPD INTERNATIONAL HOLDINGS (UK) LTD.beneficial owner
- CLINICAL TECHNOLOGY CENTRE (INTERNATIONAL) LIMITEDbeneficial owner
- WILDCAT ACQUISITION HOLDINGS (UK) LIMITEDbeneficial owner
- SMITH, Anthony Hugh
- director · American · appointed 2023-03-29 · Companies House
- STARR, Alison Jane
- director · British · appointed 2024-04-18 · Companies House
- BERTHOUX, Christophe
- director · French · appointed 2015-01-14 · resigned · Companies House
- CHAMBERS, Paul Michael
- director · British · appointed 2016-01-01 · resigned · Companies House
- EVANS, Hywel
- director · British · appointed 2015-02-18 · resigned · Companies House
- GREGG, Rhona
- secretary · appointed 2022-11-29 · resigned · Companies House
- HARRIS, Richard Stuart
- director · British · appointed 2021-06-30 · resigned · Companies House
- HARTMAN, Brainard Judd
- director · American · appointed 2016-05-31 · resigned · Companies House
- JAMES, Julia Mary
- director · British · appointed 2016-05-31 · resigned · Companies House
- NEILD, Christopher David
- director · British · appointed 2016-05-31 · resigned · Companies House
- NORMAN, David John
- director · British · appointed 2023-03-29 · resigned · Companies House
- SYNEXUS CLINICAL RESEARCH ACQUISITIONS LIMITEDAlso holds roles at 2 other companies
- SYNEXUS CLINICAL RESEARCH LIMITEDbeneficial owner
- Synexus Clinical Research Finance Limitedbeneficial owner
- SYNEXUS CLINICAL RESEARCH LIMITEDAlso holds roles at 2 other companies
- SYNEXUS LIMITEDbeneficial owner
- SYNEXUS CLINICAL RESEARCH ACQUISITIONS LIMITEDbeneficial owner
- Synexus Clinical Research Midco No 2 LimitedAlso holds roles at 1 other company
- Synexus Clinical Research Midco No 3 Limitedbeneficial owner
- Synexus Clinical Research Topco Limited
- corporate PSC · 75–100% shares · United Kingdom · ceased 2016-11-17 · CH · PSC register
Also holds roles at 2 other companies- WILDCAT ACQUISITION HOLDINGS (UK) LIMITEDbeneficial owner
- Thermo Fisher Scientific Inc.beneficial owner
- TONDER, Riaan Van
- director · South African · appointed 2020-03-13 · resigned · Companies House
21 parties · 7 current. Ceased and resigned records are retained as history.
Common questions
- Who owns SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED?
- What is SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED's risk level?
- Where does SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED appear across sources?
Community intel
Crowd leads · unverifiedIs this your company?
Open the inbox for this record, read what has been put to it, and answer on the record. You will be asked to show that you can act for SYNEXUS CLINICAL RESEARCH MIDCO NO 1 LIMITED — nothing is disclosed before that.